Developing a Shared Decision Making Tool for Patients with Surgically Removed Non-small Cell Lung Cancer

Description

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

Conditions

Lung Non-Small Cell Carcinoma

Study Overview

Study Details

Study overview

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

The Development of a Shared Decision-Making Encounter Tool for Decisions of Adjuvant Treatment in Patients with Resected Non-Small Cell Lung Cancer

Developing a Shared Decision Making Tool for Patients with Surgically Removed Non-small Cell Lung Cancer

Condition
Lung Non-Small Cell Carcinoma
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * PATIENTS:
  • * Adults \>= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC)
  • * Appointments to discuss adjuvant treatment of resected NSCLC
  • * CLINICIANS:
  • * Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC
  • * PAG MEMBERS:
  • * Adults \>= 18 years
  • * Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG)
  • * PATIENTS
  • * Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Mayo Clinic,

Konstantinos Leventakos, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

2026-04